In the comparison of time from the beginning of the IBD treatment to the second vaccination, patients treated with 5-ASA had a significantly shorter time than patients treated with non-anti-TNFα (non-anti-TNFα (34 months) vs. 5-ASA (10 months), p < 0.05). This evidence concerns the gene TNF and inflammatory bowel disease.